For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Bone morphogenetic proteins (BMPs) are naturally occurring proteins found in the human body. This family of proteins is involved in a myriad of cellular responses. Certain BMPs are osteoinductiveone of the three main categories of bone graftsand play an active role in bone formation and maintenance.
Scope of the Report:
The classification of Bone Morphogenetic Protein (BMP) 2 includes sponge and gel types, and the proportion of sponge in 2016 is about 99%, and the proportion will be in decreasing trend from 2017 to 2022.
Bone Morphogenetic Protein (BMP) 2 is widely used in spinal fusion, trauma surgery, oral maxillofacial surgery and reconstructive. The most proportion of Bone Morphogenetic Protein (BMP) 2 is used in spinal fusion, and the consumption proportion is about 62% in 2016.
North America is the largest consumption place, with a consumption market share nearly 70% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is concentrated. Medtronic and Cellumed are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Bone Morphogenetic Protein (BMP) 2 is expected to grow at a CAGR of roughly 2.0% over the next five years, will reach 430 million US$ in 2024, from 390 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Bone Morphogenetic Protein (BMP) 2 in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Medtronic
- Cellumed
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Sponge
- Gel
Market Segment by Applications, can be divided into
- Spinal Fusion
- Trauma Surgery
- Oral Maxillofacial Surgery
- Reconstructive
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bone Morphogenetic Protein (BMP) 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Bone Morphogenetic Protein (BMP) 2, with price, sales, revenue and global market share of Bone Morphogenetic Protein (BMP) 2 in 2017 and 2018.
Chapter 3, the Bone Morphogenetic Protein (BMP) 2 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bone Morphogenetic Protein (BMP) 2 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Bone Morphogenetic Protein (BMP) 2 market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Bone Morphogenetic Protein (BMP) 2 sales channel, distributors, customers, research findings and conclusion, appendix and data source.